Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Arcadia Biosciences, Inc. RKDA
$5.40
-$0.56 (-10.45%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
5452014.00000000
-
week52high
60.00
-
week52low
5.61
-
Revenue
9956000
-
P/E TTM
0
-
Beta
0.95536300
-
EPS
-24.47000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 20:00
Описание компании
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 03 янв 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 01 июн 2021 г. |
| Lake Street | Buy | 11 мая 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 09 февр 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 30 ноя 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 26 авг 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Schaefer Thomas J. | A | 2800 | 700 | 01 февр 2023 г. |
| Schaefer Thomas J. | A | 159000 | 50000 | 03 янв 2023 г. |
| PITLIK LAURA | A | 152000 | 23000 | 16 авг 2022 г. |
| Haley Pamela | A | 255313 | 23000 | 16 авг 2022 г. |
| Haley Pamela | A | 5088 | 700 | 01 авг 2022 г. |
| Murray Lilian Shackelford | A | 57765 | 23620 | 01 июн 2022 г. |
| Bolles Albert D. | A | 62018 | 23620 | 01 июн 2022 г. |
| Comcowich Kevin | A | 136239 | 55114 | 01 июн 2022 г. |
| WALLER GREGORY D | A | 59777 | 23620 | 01 июн 2022 г. |
| Yoder Amy | A | 63931 | 23620 | 01 июн 2022 г. |
Новостная лента
Arcadia Biosciences, Inc. (RKDA) Q1 2023 Earnings Call Transcript
Seeking Alpha
11 мая 2023 г. в 22:03
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants T.J. Schaefer – Chief Financial Officer Stan Jacot – President and Chief Executive Officer Conference Call Participants Dipesh Patel – H.C.
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2023 Financial Results and Business Highlights Conference Call
Business Wire
28 апр 2023 г. в 08:02
DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2023 after market close on May 11, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the confere.
Arcadia Biosciences, Inc. (RKDA) Q4 2022 Financial Results Transcript
Seeking Alpha
30 мар 2023 г. в 20:07
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q4 2022 Financial Results March 30, 2023 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President and Chief Executive Officer Conference Call Participants Mitchell Kapoor - H.C.
3 Stocks to Watch in the Promising Agriculture - Products Industry
Zacks Investment Research
22 мар 2023 г. в 11:29
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call
Business Wire
22 мар 2023 г. в 08:02
DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and the year's key strategic achievements.